Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.03B |
| 2 |
Tesla
TSLA
|
+$1.19B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$840M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$589M |
| 5 |
Pinduoduo
PDD
|
+$576M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.43B |
| 2 |
Apple
AAPL
|
+$1.43B |
| 3 |
Amazon
AMZN
|
+$1.25B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.22B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$923M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 10.21% |
| 3 | Financials | 9.5% |
| 4 | Consumer Discretionary | 7.6% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NWLI
3326
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.8M | ﹤0.01% |
10,498
+674
| +7% | +$165K |
|
3327
Talphera
TLPH
$74.2M
| $1.8M | ﹤0.01% |
76,247
+72,508
| +1,939% | +$2.21M |
|
3328
PUT
Diamondback Energy
FANG
$52.7B
| $1.8M | ﹤0.01% |
+68,600
| New | +$4.32M |
|
3329
PUT
Iovance Biotherapeutics
IOVA
$2.87B
| $1.8M | ﹤0.01% |
+60,000
| New | +$1.59M |
|
3330
Amneal Pharmaceuticals
AMRX
$5.79B
| $1.79M | ﹤0.01% |
515,787
+176,335
| +52% | +$747K |
|
|
NXJ
3331
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
| $1.79M | ﹤0.01% |
+133,217
| New | +$1.92M |
|
|
DCH
3332
Dauch Corp
DCH
$1.51B
| $1.79M | ﹤0.01% |
495,596
-1,614,799
| -77% | -$12M |
|
3333
PUT
Public Storage
PSA
$61.3B
| $1.79M | ﹤0.01% |
+9,000
| New | +$1.93M |
|
|
ABTX
3334
DELISTED
Allegiance Bancshares
ABTX
| $1.79M | ﹤0.01% |
74,081
+38,370
| +107% | +$1.29M |
|
3335
CALL
RingCentral
RNG
$5.28B
| $1.78M | ﹤0.01% |
8,400
+3,600
| +75% | +$741K |
|
3336
CALL
Alcon
ALC
$35B
| $1.78M | ﹤0.01% |
35,000
| – | – |
|
3337
Strategy Shares Newfound/ReSolve Robust Momentum ETF
ROMO
$25.9M
| $1.77M | ﹤0.01% |
+84,300
| New | +$2.1M |
|
3338
United Microelectronic
UMC
$46.9B
| $1.77M | ﹤0.01% |
817,127
-97,708
| -11% | -$246K |
|
3339
V2X
VVX
$2.65B
| $1.77M | ﹤0.01% |
42,675
+5,070
| +13% | +$258K |
|
3340
Twist Bioscience
TWST
$7.25B
| $1.77M | ﹤0.01% |
57,770
+13,455
| +30% | +$362K |
|
|
RUHN
3341
DELISTED
Ruhnn Holding Limited American Depositary Shares
RUHN
| $1.76M | ﹤0.01% |
400,028
| – | – |
|
3342
Collegium Pharmaceutical
COLL
$956M
| $1.75M | ﹤0.01% |
107,498
-138,655
| -56% | -$2.86M |
|
|
BPMC
3343
PUT
DELISTED
Blueprint Medicines
BPMC
| $1.75M | ﹤0.01% |
30,000
-600
| -2% | -$38.6K |
|
3344
PUT
Carvana
CVNA
$77.9B
| $1.75M | ﹤0.01% |
159,000
+4,500
| +3% | +$69.6K |
|
3345
PUT
Roku
ROKU
$22.7B
| $1.75M | ﹤0.01% |
+20,000
| New | +$2.3M |
|
|
LGTY
3346
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $1.75M | ﹤0.01% |
123,168
-6,651
| -5% | -$98.3K |
|
3347
Savara
SVRA
$1.19B
| $1.75M | ﹤0.01% |
824,829
+731,496
| +784% | +$2.01M |
|
3348
PUT
Novartis
NVS
$297B
| $1.75M | ﹤0.01% |
21,200
-28,800
| -58% | -$2.57M |
|
3349
Primis Financial Corp
FRST
$404M
| $1.74M | ﹤0.01% |
176,336
-10,384
| -6% | -$145K |
|
3350
Manitowoc
MTW
$675M
| $1.73M | ﹤0.01% |
203,801
-75,125
| -27% | -$980K |
|
Similar funds
Goldman Sachs's Q1 2020 Portfolio in Review
As of Q1 2020, Goldman Sachs held 5,784 positions worth $284B, down 28% from $393B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs withdrew a net $27.9B in Q1 2020, closing 606 positions and reducing 2,198 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $731M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Vertiv worth $138M.
- Goldman Sachs's largest Q1 2020 buy was Vertiv: 15,967,049 shares worth $138M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $4.03B increase.
- Goldman Sachs's biggest Q1 2020 reduction was Microsoft, cutting an estimated $2.43B.
- Goldman Sachs fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $731M.
- Goldman Sachs's ten largest holdings make up 18% of its $284B portfolio in Q1 2020.
- Goldman Sachs opened 600 new positions and closed 606 in Q1 2020.
- Goldman Sachs's portfolio value fell 28% quarter-over-quarter to $284B.
Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.